Ensayos clínicos

8.676 ensayos encontrados

CompletadoFase 2ClinicalTrials.gov

A Phase 2, Open-Label, 2-Cohort Study of INCB050465, a PI3Kδ Inhibitor, in Subjects With Relapsed or Refractory Marginal Zone Lymphoma With or Without Prior Exposure to a BTK Inhibitor (CITADEL-204)

INTERVENTIONALInicio: 18 de dic de 2017ID: NCT03144674

CompletadoFase 3ClinicalTrials.gov

(OPERA)Randomized Clinical Trial to Examine Whether Peri-operative Intake of n-3 Polyunsaturated Fatty Acids Will Reduce the Occurrence of Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

INTERVENTIONALInicio: 1 de ago de 2010ID: NCT00970489

ReclutandoFase 2ClinicalTrials.gov

A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

INTERVENTIONALInicio: 9 de oct de 2024ID: NCT06470048

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Lenvatinib (E7080/MK-7902) Versus Pembrolizumab and Placebo as First Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Cisplatin-ineligible Participants Whose Tumors Express PD-L1, and in Participants Ineligible for Any Platinum-containing Chemotherapy Regardless of PD-L1 Expression (LEAP-011)

INTERVENTIONALInicio: 6 de may de 2019ID: NCT03898180

CompletadoFase 2ClinicalTrials.gov

A Phase 1/2 First-in-Human Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors

INTERVENTIONALInicio: 6 de dic de 2017ID: NCT03369223

CompletadoFase 3ClinicalTrials.gov

A 12-week Open-label, Randomised, Parallel-group, Multicentre, Phase IIIb Study to Compare the Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe and Simvastatin in Patients With Hypercholesterolaemia and CHD

INTERVENTIONALInicio: 1 de ago de 2007ID: NCT00525824

CompletadoFase 2ClinicalTrials.gov

Phase 1/2a First-In-Human Study of BMS-986207 Monoclonal Antibody Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors

INTERVENTIONALInicio: 30 de nov de 2016ID: NCT02913313

TerminadoFase 3ClinicalTrials.gov

A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of ASA404 in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Locally Advanced or Metastatic (Stage IIIb/IV) Non-Small Cell Lung Cancer (NSCLC)

INTERVENTIONALInicio: 1 de abr de 2008ID: NCT00662597

CompletadoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled Study Assessing the Effect of RO4607381 on Cardiovascular Mortality and Morbidity in Clinically Stable Patients With a Recent Acute Coronary Syndrome

INTERVENTIONALInicio: 1 de abr de 2008ID: NCT00658515

CompletadoClinicalTrials.gov

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) in a Vulnerable Neighbourhood, Buenos Aries Argentina

OBSERVATIONALInicio: 10 de jun de 2020ID: NCT04472078

Activo, no reclutaClinicalTrials.gov

A Multicenter, Prospective, Non-selection Study for Endometrial Receptivity Analysis Test in Patients With Previous Implantation Failures

OBSERVATIONALInicio: 16 de ene de 2024ID: NCT06097559

CompletadoFase 3ClinicalTrials.gov

A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects With Schizophrenia

INTERVENTIONALInicio: 1 de may de 2012ID: NCT01515423

ReclutandoClinicalTrials.gov

Atrial Electromechanical Alteration as a Predictor of Arrhythmias in the Postoperative Period After Cardiovascular Surgery

OBSERVATIONALInicio: 6 de feb de 2026ID: NCT07388108

CompletadoFase 2ClinicalTrials.gov

A 3-part Open-label Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Compare the Efficacy, Safety and Tolerability of 8 Weeks of Treatment With Lanthanum Carbonate and Calcium Carbonate Using a Crossover Design and Investigate the Efficacy and Safety of 8 Months of Treatment With Lanthanum Carbonate in Hyperphosphataemic Children and Adolescents Aged 10 Years to <18 Years With Chronic Kidney Disease on Dialysis

INTERVENTIONALInicio: 15 de feb de 2013ID: NCT01696279

CompletadoFase 3ClinicalTrials.gov

Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in WA17822

INTERVENTIONALInicio: 1 de ago de 2005ID: NCT00721123

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Active-Controlled, Double-Blind Study Comparing Upadacitinib (ABT-494) to Abatacept in Subjects With Moderately to Severely Active Rheumatoid Arthritis With Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs) on Stable Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs (csDMARDs)

INTERVENTIONALInicio: 9 de may de 2017ID: NCT03086343

TerminadoFase 3ClinicalTrials.gov

A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus

INTERVENTIONALInicio: 1 de ago de 2007ID: NCT00496158

TerminadoFase 3ClinicalTrials.gov

Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

INTERVENTIONALInicio: 30 de sept de 2020ID: NCT04419558

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Dupilumab for the Treatment of Pruritus of Lichen Simplex Chronicus (LSC) in Adults

INTERVENTIONALInicio: 25 de nov de 2024ID: NCT06687980

DesconocidoClinicalTrials.gov

Incidence and Implications With the Use of Nasal Cannulas During COVID-19

OBSERVATIONALInicio: 30 de abr de 2020ID: NCT04376580